Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 31

    New report on global connected health market out

    New report on global connected health market out

    savita thakur thakur5 Aug 2016 9:09 AM IST
    London : Technavio’s latest report on the global connected health market provides an analysis on the most important trends expected to impact the...
    Ziqitza Healthcare bags two awards at CIMS Healthcare Excellence Awards 2016

    Ziqitza Healthcare bags two awards at CIMS Healthcare Excellence Awards 2016

    savita thakur thakur4 Aug 2016 1:01 PM IST
    Mumbai : Emergency Medical Services provider Ziqitza Healthcare Ltd (ZHL) recently bagged two awards at the CIMS Healthcare Excellence Awards 2016....
    Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis

    Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis

    savita thakur thakur29 July 2016 1:38 PM IST
    Mumbai : Sun Pharma, , and its wholly owned subsidiary and Almirall have recently announced a licensing agreement on the development and...
    FDA approves Adlyxin to treat type 2 diabetes

    FDA approves Adlyxin to treat type 2 diabetes

    savita thakur thakur29 July 2016 1:37 PM IST
    The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along...
    FDA updates warnings for fluoroquinolone antibiotics

    FDA updates warnings for fluoroquinolone antibiotics

    savita thakur thakur28 July 2016 12:45 PM IST
    The U.S. Food and Drug Administration approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about...
    Ziqitzas emergency medical service unit to make a foray into Dubai

    Ziqitza's emergency medical service unit to make a foray into Dubai

    savita thakur thakur28 July 2016 12:44 PM IST
    Mumbai : Ziqitza Gulf Medical Response and Ambulance Services (GMRAS), a subsidiary of Ziqitza Healthcare Ltd recently won a tender to service the...
    Columbia Asia Receives $101M ( Rs 680 cr Appx) Investment from Mitsui & Co.

    Columbia Asia Receives $101M ( Rs 680 cr Appx) Investment from Mitsui & Co.

    savita thakur thakur27 July 2016 8:09 PM IST
    Columbia Asia, one of the largest and healthcare companies in Asia, announced today it is receiving $101 million in investment from Mitsui & Co.,...
    Whitepaper on E-pharmacies released

    Whitepaper on E-pharmacies released

    savita thakur thakur26 July 2016 1:08 PM IST
    New Delhi : The Federation of Indian Chambers of Commerce and Industry (FICCI) an apex business organization in association with Frost & Sullivan,...
    USFDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include treatment-naïve adults

    USFDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include treatment-naïve adults

    savita thakur thakur25 July 2016 11:20 AM IST
    Ridgefield : The U.S. Food and Drug Administration has approved an expanded indication for Synjardy® (empagliflozin and metformin hydrochloride)...
    Positive Bioscience launches Academy for training Oncologists in Genomics

    Positive Bioscience launches Academy for training Oncologists in Genomics

    savita thakur thakur23 July 2016 11:01 AM IST
    Positive Bioscience launched Positive Academy for Training in Genomics and Clinical applications (ATGC), an initiative to help oncologists gain...
    FDA approves new medication for dry eye disease

    FDA approves new medication for dry eye disease

    savita thakur thakur14 July 2016 1:18 PM IST
    The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease....
    FDA Approves Repatha- First And Only Single Monthly Injection For A PCSK9 Inhibitor

    FDA Approves Repatha- First And Only Single Monthly Injection For A PCSK9 Inhibitor

    savita thakur thakur14 July 2016 1:17 PM IST
    Calif. : Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha® (evolocumab) Pushtronex™ system (on-body infusor...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok